Human genome editing: From the First to the Third International Summit
By Françoise Baylis,
Impact Ethics
| 03. 22. 2023
photo by Miguel Descart licensed under CC BY-SA 2.0
In early March, I was in London, England for the Third International Summit on Human Genome Editing. It was a welcome occasion to see friends and colleagues and to advance discussion and debate on research involving somatic, germline, and heritable human genome editing.
Somatic human genome editing involves the genetic modification of somatic (nonreproductive) cells. Changes made to these cells are not passed on to subsequent generations. Germline human genome editing involves the genetic modification of reproductive cells (eggs and sperm) or early stage (one-cell) embryos. This research occurs in the lab and when the research is done the modified cells are discarded. Heritable human genome editing involves the transfer of genetically modified reproductive cells to a uterus in the hope of creating genetically modified children.
In this brief commentary, I share my reflections on two of the many successes of the Third International Summit: (1) increased focus on the science, ethics, and governance of somatic human genome editing and (2) public acknowledgment of the need for further discussion and...
Related Articles
By Emma McDonald Kennedy
| 10.29.2026
At the beginning of Nathan Fielder and Lance Oppenheim’s blockbuster documentary You Can See Everything, Billy Evans (partner of Theranos founder and convicted fraudster Elizabeth Holmes), says that they decided to do the film for one purpose: “radical transparency.” As they work on “Theranos 2.0,” Evans and Holmes want to show the public that she has been misunderstood –– painted as a liar and a fraud in the public imagination (and the courts) despite, as she claims in the...
By Jan Grue, The Guardian | 10.27.2026
For a very long time, I dreamed of being cured. I was born in 1981. I learned to walk early enough, but I stumbled and fell more easily than other children. My parents began to worry that something was wrong...
By Gary Sernovitz, Bloomberg | 10.21.2026
Three years ago, at the age of 50, I found out I have dangerous genes. So in June, I went to Cambridge, Massachusetts, to see how they could be fixed. Among my 6 billion base pairs of DNA are two...
By Carl Zimmer, The New York Times | 10.20.2026
For the first time, scientists say they have used viruses designed by artificial intelligence to treat a human patient.
Researchers announced on Tuesday that they had administered the virus, known as a phage, to a patient suffering from a deadly...